These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Evaluation of solid-state forms present in tablets by Raman spectroscopy. Taylor LS; Langkilde FW J Pharm Sci; 2000 Oct; 89(10):1342-53. PubMed ID: 10980509 [TBL] [Abstract][Full Text] [Related]
3. Quantitative determination of diclofenac sodium in solid dosage forms by FT-Raman spectroscopy. Mazurek S; Szostak R J Pharm Biomed Anal; 2008 Nov; 48(3):814-21. PubMed ID: 18819768 [TBL] [Abstract][Full Text] [Related]
4. Quantitative analysis of enalapril by 1H NMR spectroscopy in tablets. Zoppi A; Linares M; Longhi M J Pharm Biomed Anal; 2005 Mar; 37(3):627-30. PubMed ID: 15740927 [TBL] [Abstract][Full Text] [Related]
5. Molecular properties of flurbiprofen and its solid dispersions with Eudragit RL100 studied by high- and low-resolution solid-state nuclear magnetic resonance. Mollica G; Geppi M; Pignatello R; Veracini CA Pharm Res; 2006 Sep; 23(9):2129-40. PubMed ID: 16952004 [TBL] [Abstract][Full Text] [Related]
6. Assessment of mefenamic acid polymorphs in commercial tablets using chemometric coupled to MIR and NIR spectroscopies. Prediction of dissolution performance. Antonio M; Maggio RM J Pharm Biomed Anal; 2018 Feb; 149():603-611. PubMed ID: 29202439 [TBL] [Abstract][Full Text] [Related]
7. Comparison of the analytical methods (solid state NMR, FT-IR, PXRD) in the analysis of the solid drug forms with low concentration of an active ingredient - 17-β-estradiol case. Szeleszczuk Ł; Jurczak E; Zielińska-Pisklak M; Harwacki J; Pisklak DM J Pharm Biomed Anal; 2018 Feb; 149():160-165. PubMed ID: 29121569 [TBL] [Abstract][Full Text] [Related]
8. Rapid verification of identity and content of drug formulations using mid-infrared spectroscopy. Ryan JA; Compton SV; Brooks MA; Compton DA J Pharm Biomed Anal; 1991; 9(4):303-10. PubMed ID: 1911982 [TBL] [Abstract][Full Text] [Related]
9. Quantitation of a polymorphic mixture of an active pharmaceutical ingredient with solid state (13)C CPMAS NMR spectroscopy. Virtanen T; Maunu SL Int J Pharm; 2010 Jul; 394(1-2):18-25. PubMed ID: 20416365 [TBL] [Abstract][Full Text] [Related]
11. The use of 13C labeling to enhance the sensitivity of 13C solid-state CPMAS NMR to study polymorphism in low dose solid formulations. Booy KJ; Wiegerinck P; Vader J; Kaspersen F; Lambregts D; Vromans H; Kellenbach E J Pharm Sci; 2005 Feb; 94(2):458-63. PubMed ID: 15614820 [TBL] [Abstract][Full Text] [Related]
12. Electrochemical monitoring of piroxicam in different pharmaceutical forms with multi-walled carbon nanotubes paste electrode. Abbaspour A; Mirzajani R J Pharm Biomed Anal; 2007 May; 44(1):41-8. PubMed ID: 17324550 [TBL] [Abstract][Full Text] [Related]
13. Investigation of the Sensitivity of Transmission Raman Spectroscopy for Polymorph Detection in Pharmaceutical Tablets. Feng H; Bondi RW; Anderson CA; Drennen JK; Igne B Appl Spectrosc; 2017 Aug; 71(8):1856-1867. PubMed ID: 28357920 [TBL] [Abstract][Full Text] [Related]
14. [Technological and pharmacotherapeutic properties of selected drugs with modified release of diclofenac sodium]. Kołodziejczyk MK; Kołodziejska J; Zgoda MM Polim Med; 2012; 42(2):121-32. PubMed ID: 23016443 [TBL] [Abstract][Full Text] [Related]
15. Quantitative polymorph contaminant analysis in tablets using Raman and near infra-red spectroscopies. Hennigan MC; Ryder AG J Pharm Biomed Anal; 2013 Jan; 72():163-71. PubMed ID: 23146243 [TBL] [Abstract][Full Text] [Related]
16. The influence of polymorphism on the manufacturability and in vitro dissolution of sulindac-containing hard gelatin capsules. Guadalupe Sánchez-González E; Yépez-Mulia L; Jesús Hernández-Abad V; Jung Cook H Pharm Dev Technol; 2015 May; 20(3):306-13. PubMed ID: 24417644 [TBL] [Abstract][Full Text] [Related]
17. 19F solid-state NMR spectroscopic investigation of crystalline and amorphous forms of a selective muscarinic M3 receptor antagonist, in both bulk and pharmaceutical dosage form samples. Wenslow RM Drug Dev Ind Pharm; 2002 May; 28(5):555-61. PubMed ID: 12098844 [TBL] [Abstract][Full Text] [Related]
18. Pharmaceutical properties of two ethenzamide-gentisic acid cocrystal polymorphs: Drug release profiles, spectroscopic studies and theoretical calculations. Sokal A; Pindelska E; Szeleszczuk L; Kolodziejski W Int J Pharm; 2017 Apr; 522(1-2):80-89. PubMed ID: 28274662 [TBL] [Abstract][Full Text] [Related]
19. ¹³C cross-polarization magic-angle spinning nuclear magnetic resonance analysis of the solid drug forms with low concentration of an active ingredient-propranolol case. Pisklak DM; Zielińska-Pisklak M; Szeleszczuk L; Wawer I J Pharm Biomed Anal; 2014 May; 93():68-72. PubMed ID: 23911072 [TBL] [Abstract][Full Text] [Related]
20. ¹³C solid-state NMR analysis of the most common pharmaceutical excipients used in solid drug formulations, Part I: Chemical shifts assignment. Pisklak DM; Zielińska-Pisklak MA; Szeleszczuk Ł; Wawer I J Pharm Biomed Anal; 2016 Apr; 122():81-9. PubMed ID: 26845204 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]